Category Marginal Zone Lymphoma

Immunotherapy, Marginal Zone Lymphoma, Researcher Spotlight

Reid Merryman, MD

Researcher Spotlight: Reid Merryman, MD Dana-Farber Cancer Institute Marginal zone lymphoma (MZL) is a slow-growing B-cell NHL that has a relatively low number of new diagnoses each year. As a result, few clinical trials are available for MZL patients, including…

Nichole Musumeci
05/13/2019

Follicular Lymphoma, Marginal Zone Lymphoma, Researcher Spotlight

Manali Kamdar, MBBS

Researcher Spotlight: Manali Kamdar, MBBS University of Colorado Patients with indolent (slow-growing) lymphomas such as follicular (FL) or marginal zone (MZL) are chronic, frequently relapsing diseases which can vary widely in clinical presentation. Therapies are varied and can often include…

Nichole Musumeci
05/13/2019

Reid Merryman, MD

Manali Kamdar, MBBS

Subscribe to Our Emails. Get lymphoma and CLL resources and updates.